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1162-103 Effect of Left Ventricular Function on Long-Term Left 
Ventricular Pacing and Sensing Threshold 
Huno-Fat Tsa, Chu-Pak Lau, Vince Paul, Giuseppe Boriani, Schuchert Andreas, Juan 
Leal Del Ojo, K. Malinowski, Jean-Jacques Blanc, Department of Medicine, University of 
/'long Kong, Queen Mary Hospital, l-long Kong, l-long Kong. 
Background. The effect of left ventdcular (LV) systolic function on the long-term LV pec-- 
ing and sensing threshold is unclear. 
Methods. We studied the effect of LV ejection fraction (LVEF) on the LV pacing and sens- 
ing threshold in 56 patients (pts)(mean age: 70.2-+10.5 years) enrolled in study evaluat- 
ing the safety and efficacy of the Aescula TM Left Heart Lead, Model 1055K (St. Jude 
Medical, USA). 49 pts (88%) and 7 pts (12%) were implanted for conventional pace- 
maker (sick sinus syndrome=14, heart block=20 or atrial fibrillation 9) and heart failure 
indications, respectively. 28 pts had LVEF _<40% (Gp 1), and remaining 28 patients had 
LVEF >40% (Gp 2). The LV pacing and sensing threshold, and lead impedance were 
measured during implant and at 3 month (M) follow up. 
Results. The LV pacing lead was successfully implanted in all pts without any dislodge- 
ment on follow-up. At implant, Gp 1 had a significantly lower R wave amplitude and lead 
impedance, but a similar LV pacing threshold vs. Gp 2 (Table 1). At 3 M, Gp 1 had a sig- 
nificantly higher LV pacing threshold but similar R wave amplitude and lead impedance 
vs. Gp 2 (Table 1 ). 
Conclusions. Our results suggest that LV sytolic function have a significant impact on the 
long-term LV pacing threshold. Depsite the similar LV pacing threshold during implant, 
pts with impaired LV function had significant increase in LV pacing threshold on follow- 
up. This finding has important implication on programming of pacing output to ensure LV 
capture for pacing therapy in congestive heart failure. 
LV Pacing Threshold R Wave Impedance (~) 
(V at 0.5 ms) Amplitude (mV) 
Mean LVEF Implant 3 M Implant 3 M Implant 3M 
(%) 
Gp 1 27¢8 1.3_+0.7 2.2±1.2 + 7.0±3.2 6.6±3.9 687±193 708±195 
Gp2 62¢10 1.5¢1.0 1.6_+0.8" 9.7_+3.4* 8.0-J:4.0 875±344" 739-+147 
(*p<0.05 vs. Gp 1, +p<0.05 vs. Implant) 
1162-104 Short-Term Effects of Cardiac Resynchronization on 
Brain Natrluretic Peptide Release in Patients With 
Systol ic Heart Failure and Ventricular Conduct ion 
Diaturbance 
Karsten Filzmaier. Anil M. Sinha, Ole A. Breithardt, Hugo Stiegler, Yudko Fischer, J5rgen 
Graf, Karl Mischke, Christoph Stellbrink, University Hospital Aachen, Medical Clinic/, 
Aachen, Germany, University Hospital Aachen, Department of Clinical Chemistry, 
Aachen, Germany. 
Background: Brain natriuretic protein (BNP) is highly expressed in pathological hemody- 
namic conditions and correlates with left ventricular ejection fraction (EF), left ventricular 
wall stress and pressure or volume overload. Cardiac resynchronization by biventricular 
(BiV) pacing has recently been shown to improve hemodynamics acutely in patients (pts) 
with advanced systolic heart failure (HF) and left bundle branch block (LBBB). We inves- 
tigated the effects of short-term BiV-pacing on BNP levels in pts with HF. 
Methods: 12 pts. (7 male, 5 female) with severe HF (mean EF 24 +/- 5 %, NYHA It 3 pts, 
NYHA III 8 pts, NYHA IV 2 pt.) who underwent implantation of a BiV pacemaker were 
included in the study. 7 pts suffered from dilative and 5 from ischemic cardiomyopathy. 
BNP levels were determined with the Triage BNP test (Biosite Diagnostics, San Diego, 
USA). Blood samples for BNP were taken at rest on the day before surgery and 4-6 days 
after pacemaker implantation after continuous BiV pacing. The pacemaker was pro- 
grammed to the atrial triggered BiV paced (VDD) mode immediately after implantation 
with an atrioventricular delay of 121 ± 21 ms. As BNP levels are elevated in patients with 
impaired renal function, Creatinine and blood urea nitrogen (BUN) levels were measured 
at the same time points. Left ventdcuiar EF was determined echocardiographically. 
Results: None of the pts had severely impaired renal funtion at baseline (Creatinine: 1,4 
± 0,4 mg/dl; BUN: 61 ± 21 mg/dl). Initial BNP levels were abnormal in all pts. with a mean 
of 537 ± 306 pg/ml (range 102-1030 pg/rnl). After 4-6 days of continuous BiV pacing BNP 
levels decreased significantly to 255 ± 200 pg/ml (range 32-667 pg/ml, p<0,005). Craati- 
nine and BUN levels showed no significant increase after surgery (1,4 ± 0,4 mg/dl, 62 ± 
32 mg/dl; p=n.s.). 
Conclusion: Cardiac resynchronization by BiV pacing leads to a significant decrease in 
BNP release as an indicator for improved hemodynamics and a better neurohormonal 
status after short term BiV pacing. Thus, rnonitoring BNP can potentially be used as a 
marker for the therapeutic effect of BiV pacing in pts. with advanced HF and ventricular 
conduction disturbance. 
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1162-119 Biventrlcular Pacing In Patients With Hypertrophic 
Cerdlomyopethy: Beneficial Effect on Exercise 
Tolerance and Symptomatic Status 
Christooher A. Rinaldi. Cliff A. Bucknail, Ron D. Simon, Pier Lambiase, Artur Baszko, 
Julian Bostock, Donna Elliott, Jaswinder S. Gill, Guys and St Thomas NHS Trust, 
London, United Kingdom. 
Background: Biventdcular (BIV) pacing is beneficial in patients with heart failure and pro- 
longed QRS duration. We assessed its benefit in patients with hypertrophic ardiomyop- 
athy (HCM) and intraventricular conduction delay with normal systolic function. 
Methods: Seven patients aged 57±8yrs with HCM and prolonged QRS underwent BIV 
pacing with placement of electrodes in the right ventdcular (RV) apex and a branch of the 
coronary sinus to allow left ventdcular pacing. An atrial electrode was also inserted to 
achieve sequential BIV pacing with a short AV delay of 78 msecs. Symptomatic status 
and treadmill exercise tolerance was assessed after 1 month in each pacing modality 
Results: There was a significant improvement in NYHA class with both active pacing 
modalitias although the improvement appeared greater in BIV mode. When symptomatic 
status was assessed using the Minnesota Living with Heart Failure questionnaire there 
was only a statistically significant improvement with BIV pacing as compared to baseline 
(71 ±3 vs 40±33, p<0.05). Exercise duration increased with both active pacing modalities 
but only in BIV pacing did this reach statistical significance (231±171 vs 300¢208, 
p<0.05). Conclusion: BIV pacing in patients with HCM and prolonged QRS has beneficial 
effects on both exercise tolerance and symptoms which exceeds that of RV pacing. 
1162-120 Pacing Mode and Pacing Site Determine the Amount of 
Hemodynamic Response in Resynchronization Therapy 
Jueroen Voat. Barbara Lamp, Johannes Heintze, Bert Hansky, Leon Krater, Frank 
Warzok, Reiner Koerfer, Dieter Horstkotte, Heart Center North Rhine-Westphalia, Bad 
Oeynhausen, Gerrnan v 
In resynchronisation therapy the posterolateral (PL) free wall has been identified as the 
optimal pacing site in contrast to the anterior or inferior wall. Although in the majority of 
clinical studies patients (pts.) are paced biventricular (BiV), no data are available on indi- 
vidual differences between left ventricular (LV) and BiV pacing. 
We report on the preoperative hemodynamic test procedure in 86 heart failure pts. with 
sinus rhythm (age 62±9 years, 24 women, NYHA 3.1, 50 pts. with DCM, 34 pts. with 
CAD, QRS-width 192±22 ms, PQ interval 222±42 ms). Artedal pulse pressure (PP) was 
measured during atrio-LV and atrio-BiV pacing (VAT-mode) at different AV-delays using 
electrophysiology catheters in right atrium, right ventdcular apex (RVA) and poaterolat- 
eral coronary veins (CV). In 14 pts. 2 alternate PL CV and in 17 pts. RV outflow tract 
(RVOT) were tested. 
13 pts were non responders (PP response below 10%). At the optimal AV-delay the best 
hemodynamic response was BV in 41, LV in 30 and BV with RVOT in 2 pts. The individ- 
ual difference in PP increase between BV- and LV pacing mode at optimal AV-delay was 
3 to 59%. 13 pts. showed response only by changing from BiV to LV (7 pts.), from LV to 
BiV (4), and from BiV+RVA to BiV+RVO (2 pts.). In 14 pts. with alternate PL veins the dif- 
ference of PP increase between those tested veins was 4 to maximal 18%. In 4 pts. a 
sufficient response could only be seen by testing the second PL vein. The rosponders 
were implanted and programmed to the identified optimal mode and site. 
Without preoperative testing of pacing mode and site 30% (26/86) of pts. would have 
been implanted without significant acute response. 43 % (32/73) of respooders did not 
have their optimal hemodynamic response at BiV pacing. Thus preimplant esting of dif- 
ferent sites including alternate PL CV and RVOT has an impact on implantation fre- 
quency (economics) and probably on clinical follow up and results of outcome studies. 
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857-1 Molecular Autopsy for HERG Defects In Sudden Infant 
Death Syndrome 
Michael J. Ackerman. Blake D. Anson, David J. Tester, Jeffrey A. Towbin, William Q. 
Stumer, Craig T. January, Mayo Clinic/Mayo Foundation, Rochester, Minnesota, 
University of Wisconsin, Madison, Madison, Wisconsin. 
Background: Fatal arrhythmias from occult long QT syndrome (LQTS) may be responsi- 
ble for some cases of sudden infant death syndrome (SIDS). Recently, we have estab- 
lished cardiac ion channelopathies as a pathogenic mechanism for SIDS, identifying 
defects in the cardiac sodium channel, BCN5A, in 2% of cases. Here, the prevalence and 
functional properties of putative SIDS-cauaing mutations in the cardiac potassium chan- 
nel gene, HERG (KCNH2), are determined. 
Methods: Postmortem molecular analysis was performed on 93 cases of SIDS or unde- 
termined infant death identified by the Medical Examiner's Office of the Arkansas State 
Crime Laboratory between September 1997 and August 1999. Genomic DNA was 
extracted from frozen myocardium and subjected to HERG mutational analysis using 
polymerase chain reaction, denaturing high performance liquid chromatography, and 
DNA sequencing. Missenss mutations were incorporated into the expression vector 
